Given that ADAM8 in nasal secretions can be collected and assayed non-invasively, it holds potential as a novel biomarker for preoperatively distinguishing CRSwNP endotypes and the prognostication of postoperative disease control status. Here, ADAM8 is linked to chronic rhinosinusitis with nasal polyps.